HOOKIPA Pharma Inc (HOOK)
0.80
-0.24
(-23.08%)
USD |
NASDAQ |
May 24, 16:00
0.80
0.00 (0.00%)
After-Hours: 05:32
HOOKIPA Pharma Enterprise Value: -12.45M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | -12.45M |
| May 23, 2024 | 11.30M |
| May 22, 2024 | 5.364M |
| May 21, 2024 | -6.797M |
| May 20, 2024 | -6.609M |
| May 17, 2024 | -10.92M |
| May 16, 2024 | -11.36M |
| May 15, 2024 | -6.609M |
| May 14, 2024 | -9.993M |
| May 13, 2024 | -15.78M |
| May 10, 2024 | -15.61M |
| May 09, 2024 | -12.45M |
| May 08, 2024 | -12.45M |
| May 07, 2024 | -9.775M |
| May 06, 2024 | -4.501M |
| May 03, 2024 | 0.4364M |
| May 02, 2024 | -0.7807M |
| May 01, 2024 | -2.651M |
| April 30, 2024 | -3.809M |
| April 29, 2024 | 1.505M |
| April 26, 2024 | -3.215M |
| April 25, 2024 | -11.84M |
| April 24, 2024 | -7.499M |
| April 23, 2024 | -15.91M |
| April 22, 2024 | -21.65M |
| Date | Value |
|---|---|
| April 19, 2024 | -19.08M |
| April 18, 2024 | -15.92M |
| April 17, 2024 | -16.16M |
| April 16, 2024 | -11.47M |
| April 15, 2024 | -16.40M |
| April 12, 2024 | -13.78M |
| April 11, 2024 | -11.93M |
| April 10, 2024 | -9.488M |
| April 09, 2024 | -8.350M |
| April 08, 2024 | -7.499M |
| April 05, 2024 | -17.07M |
| April 04, 2024 | -17.69M |
| April 03, 2024 | -15.51M |
| April 02, 2024 | -16.40M |
| April 01, 2024 | -20.02M |
| March 31, 2024 | -21.15M |
| March 28, 2024 | -45.52M |
| March 27, 2024 | -44.69M |
| March 26, 2024 | -44.83M |
| March 25, 2024 | -46.45M |
| March 22, 2024 | -45.61M |
| March 21, 2024 | -44.33M |
| March 20, 2024 | -45.43M |
| March 19, 2024 | -43.22M |
| March 18, 2024 | -44.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-85.79M
Minimum
Sep 25 2023
458.52M
Maximum
May 18 2021
58.70M
Average
34.13M
Median
Enterprise Value Benchmarks
| Merck & Co Inc | 356.63B |
| Absci Corp | 321.59M |
| NovaBay Pharmaceuticals Inc | 5.655M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 27.27M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 14.38M |
| Revenue (Quarterly) | 36.60M |
| Total Expenses (Quarterly) | 21.99M |
| EPS Diluted (Quarterly) | 0.11 |
| Profit Margin (Quarterly) | 39.30% |
| Earnings Yield | -62.50% |
| Normalized Earnings Yield | -61.24 |